È sicuro di voler terminare?
Chiudendo, la configurazione personalizzata non sarà salvata, a meno che l'articolo non sia stato aggiunto al carrello della spesa o ai prodotti preferiti.
Clicchi OK per chiudere MILLIPLEX® MAP, oppure Annulla per tornare alla selezione.
Scelga pannelli su misura e kit premiscelati, OPPURE le microsfere MAPmates™ per la trasduzione del segnale
Progetti e calcoli il prezzo dei Suoi kit MILLIPLEX® MAP.
Pannelli su misura e kit premiscelati
La nostra ampia gamma comprende pannelli multiplex che consentono di scegliere, nell'ambito del pannello, gli analiti più adatti per le Sue esigenze. Oppure Lei può scegliere le citochine premiscelate o i kit single plex.
Kit e MAPmates™ per studi di trasduzione del segnale
Scelga i kit premiscelati che permettono di esplorare interi processi e pathway. Oppure progetti kit su misura scegliendo le microsfere MAPmates™ single plex e seguendo le linee guida fornite.
Le seguenti MAPmates™ non possono essere dosate insieme:
-MAPmates™ che richiedono tamponi differenti per l'analisi.
-MAPmate™ fosfo-specifiche e totali, es GSK3β totale e GSK3β (Ser 9).
-MAPmates™ PanTyr e sito-specifiche come fosfo-recettore EGF e fosfo-STAT1 (Tyr701).
-Più di 1 fosfo-MAPmate™ per un solo bersaglio (Akt, STAT3).
-GAPDH e β-Tubulina non possono essere miscelati con kit o MAPmates™ contenenti panTyr.
.
| Numero di catalogo | Descrizione dell'ordine | Qtà/conf | Elenca |
Questo articolo è stato aggiunto ai prodotti preferiti.
Selezioni una specie, un tipo di pannello, un kit o un tipo di campione
Per cominciare a progettare il Suo kit MILLIPLEX® MAP, selezioni una specie, un tipo di pannello o un kit di Suo interesse.
| Specie |
Tipo di pannello |
Kit selezionato |
Tipo di campione |
Modifica |
| Selezioni una specie | . |
| Selezioni un tipo di pannello | . |
| Selezioni un kit | . |
| Selezioni un tipo di campione | Per alcuni pannelli, il tipo di campione determinerà quali analiti possono essere dosati insieme. |
Selezioni gli analiti preferiti, oppure scelga tra i nostri pannelli premiscelati e single plex
Progetti il Suo kit oppure scelga tra i nostri pannelli premiscelati e single plex
Custom Premix
Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
| Catalogue Number | Ordering Description | Qty/Pack | List |
Questo articolo è stato aggiunto ai prodotti preferiti.
| Specie |
|
| Tipo di pannello | |
| Kit selezionato | |
| Qtà | Numero di catalogo | Descrizione dell'ordine | Qtà/conf | Prezzo di listino |
| 96-Well Plate |
| Qtà | Numero di catalogo | Descrizione dell'ordine | Qtà/conf | Prezzo di listino |
Aggiungi altri reagenti (Le microsfere MAPmate devono essere utilizzate con un tampone ed un kit di rilevazione)
| Qtà | Numero di catalogo | Descrizione dell'ordine | Qtà/conf | Prezzo di listino |
| 48-602MAG | Buffer Detection Kit for Magnetic Beads | 1 Kit |
Opzione salva-spazio
I Clienti che ordinano diversi kit possono scegliere di ridurre lo spazio necessario per lo stoccaggio, rinunciando al confezionamento del kit e ricevendo i vari reagenti per il saggio multiplex in buste di plastica.
I Clienti che ordinano diversi kit possono scegliere di ridurre lo spazio necessario per lo stoccaggio, rinunciando al confezionamento del kit e ricevendo i vari reagenti per il saggio multiplex in buste di plastica.
Questo articolo è stato aggiunto ai prodotti preferiti.
Il prodotto è stato aggiunto al carrello.
Ora può disegnare un altro kit su misura, scegliere un kit premiscelato, procedere con il check out dell'ordine, oppure chiudere lo strumento per gli ordini on-line.
Attenzione: Ci siamo trasferiti. Non è più possibile acquistare i prodotti Merck Millipore nel sito MerckMillipore.comPer saperne di più
Merck Webinars
Upcoming and On-Demand
View upcoming and on-demand webinars to learn advanced research techniques, valuable tips and advice from leaders in their fields of scientific research.
On-Demand Webinars by Topic Area:
Upcoming Webinars
Take part in our complimentary, live webinars, where you’ll interact with experts who are breaking ground in the instrumental analytics, sample preparation, industrial microbiology, life science research, IVD/OEM, pharmaceutical and biopharmaceautical industries. You’ll learn about the newest tools and technologies while gathering valuable tips and troubleshooting strategies for the applications most relevant to your processes.Find an upcoming webinar below and register today!
Pharma and Biopharma Manufacturing
Reducing Risk and Decreasing Timelines for Biopharmaceutical Cell Line Development Through Optimized Reagents and Processes
|
Abstract: Join us to learn about challenges faced with traditional expression systems and how a CHO cell line with the glutamine synthetase knock-out via ZFN provides benefits for fast, efficient cell line development with stable and high titer expression. CHO cells with their unique characteristics, represent the major expression system within the biopharmaceutical industry. However, one of the major challenges in cell line development is to identify those rare, high-producing clones in a huge population of non-expressing or low-expressing cell lines. This leads to laborious and time consuming cell line development processes. This webinar will educate the audience about challenges faced with traditional expression systems and how the CHO cell line with the glutamine synthetase knock-out via Zinc Finger Nucleases provides benefits for fast and efficient cell line development as well as stable and high titer expression. We will explore additional cell line engineering targets that can be modified to engineer a cell line that mitigates risks and removes bottlenecks throughout the biopharmaceutical process. In this webinar, you will learn:
|
A Molecule’s Journey – Breaking Down Roadblocks to Commercial Success
|
Abstract: Every biopharma executive must make important decisions early in clinical development that will impact their molecule’s journey – and ultimately the success of their commercial strategy. The key to this success is to make the right decisions at the right time. In this webinar, our experts share some key considerations to help biopharmaceutical companies successfully advance a molecule from the laboratory to the clinic as quickly as possible without sacrificing product quality, process efficiency, or patient safety. To achieve this goal, companies must navigate the complexities associated with business planning, cell line development, process development, technology, and regulatory and risk assessment. In this webinar, you will learn:
|
Comprehensive Assessment of a Stimulus-Responsive Flocculation Polymer for Cell Culture Clarification
|
Abstract: This webinar will provide a comprehensive, holistic assessment of the effects of Clarisolve® mPAA flocculation polymer pre-treatment upon clarification and subsequent downstream chromatography steps. Flocculation is a simple method to pre-clarify high density Chinese hamster ovary (CHO) cell culture feed streams, allowing for an efficient clarification process that would otherwise not be feasible using traditional depth filters. Clarisolve® mPAA polymer is a stimulus-responsive flocculation polymer that may provide a reduced dosing dependency and lower residual polymer levels when compared to other flocculants. Cell culture pre-treatment with Clarisolve® mPAA polymer followed by clarification using Clarisolve® 60HX depth filters, enables a significant increase of harvest throughputs and allows for a single clarification stage for these high-density feed streams. Furthermore, by eliminating the need for centrifugation, pre-treatment with Clarisolve® mPAA polymer allows for the implementation of a single-use clarification train.This webinar will review the efficacy of pretreatment with a range of Clarisolve® mPAA polymer concentrations upon the clarification and purification of a CHO cell culture feed stream. These results were compared to material prepared using conventional Millistak+® HC depth filtration media to deliver a comprehensive, holistic assessment of the effects of Clarisolve® mPAA polymer pre-treatment upon the clarification and subsequent downstream chromatography steps. In this webinar, you will learn more about:
|
Overview of the Regulatory Landscape for Plastic Devices in Pharmaceutical Manufacturing
|
Abstract: This webinar highlights regulations for plastic devices in pharmaceutical manufacturing, a risk-based approach to qualifying components, and the importance of regulatory documentation. The growing complexity of therapeutics and globalization are some of the factors leading to innovative manufacturing solutions. Thanks to their flexibility and ease of use, polymeric materials are being used more frequently in the manufacturing of pharmaceuticals and biopharmaceuticals. Consequently, the development and qualification of plastic components requires a purposeful implementation of a multifaceted regulatory guidance. However, the lack of regulations specific to plastics used in pharmaceutical manufacturing systems has led to considerable uncertainty. In this webinar, you will learn:
|
Identifying Appropriate-Quality Pharmaceutical Raw Materials in an Evolving Regulatory Environment
Session 1: 3:00 AM EST, 12 AM PST, 9 AM CET View your Time Zone start time
Register Now Session 2: 11:00 AM EST, 8 AM PST, 5 PM CET View your Time Zone start time
Register Now |
Abstract: This webinar will discuss appropriate quality attributes for different raw material uses, present strategies to support identification, selection and risk assessment of raw materials, and highlight the importance of regulatory documentation. Recent and continuing regulatory improvements require drug manufacturers to assess and mitigate risk throughout their entire processes. This includes raw materials used at every stage of manufacturing and clinical phases. Current regulatory guidelines and industry standards clearly define quality requirements for raw materials that are incorporated into, or used close to, final drug product, for example active ingredients and excipients. However, no such clear standards are defined for chemicals used earlier in the process, such as in upstream bioprocessing, early chemical synthesis stages, or clean-in-place. The absence of such standards presents a challenge to efficiently and effectively source raw materials with appropriate supply chain transparency and control, accompanied by the necessary supporting documentation. In this webinar, you will learn:
|